| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $7.4M | -0.7% |
| Cost of Revenue | $3.8M | -0.5% |
| Gross Profit | $3.5M | -0.8% |
| R&D Expense | $562K | +2.9% |
| SG&A Expense | $2.9M | -8.3% |
| Operating Income | -$918K | +2.3% |
| Pre-tax Income | -$878K | +2.3% |
| Income Tax | $14K | +180.0% |
| Net Income | -$892K |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6K | +0.0% |
| Short-term Investments | $100K | -60.0% |
| Accounts Receivable | $553K | -24.5% |
| Current Assets | $2.1M | -18.3% |
| Total Assets | $3.5M | -12.3% |
| Current Liabilities | $1.3M | +6.0% |
| Total Liabilities | $1.3M | +6.0% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$130K | -142.3% |
| Capital Expenditures | $15K | +0.0% |
| Investing Cash Flow | $150K | +156.6% |
| Financing Cash Flow | -$50K | +0.0% |
| Free Cash Flow | -$145K | -149.7% |
| +1.3% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Stockholders' Equity |
| $2.1M |
| -20.7% |